Hepatoblastoma — Trials

Hepatoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 11
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04093648	T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)	withdrawn	Phase 1	0	Baylor College of MedicineOTHER	0	May 20, 2020	clinicaltrials
NCT02011126	Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors	withdrawn	Phase 2	0	Children's Oncology GroupNETWORK	0	Aug 7, 2018